{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:06:10Z","timestamp":1788505570947,"version":"build-2803163510"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006668","name":"Oregon Health and Science University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000801","name":"Bayer HealthCare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["Medicines360"],"award-info":[{"award-number":["Medicines360"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.contraception.2020.05.017","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T19:14:48Z","timestamp":1591211688000},"page":"143-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Oral contraceptive generations \u2013 Time to stop using a marketing myth to define nomenclature"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5967-8180","authenticated-orcid":false,"given":"Mitchell D.","family":"Creinin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4733-1224","authenticated-orcid":false,"given":"Jeffrey T.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2020.05.017_b0005","article-title":"Combined oral contraceptives: venous thrombosis","volume":"3","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2020.05.017_b0010","unstructured":"World Health Organization. Introduction to drug utilization research. World Health Organization; 2003. Available at https:\/\/apps.who.int\/medicinedocs\/en\/d\/Js4876e\/6.html. Accessed May 20, 2020."},{"key":"10.1016\/j.contraception.2020.05.017_b0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/bmj.2.5703.203","article-title":"Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs","volume":"2","author":"Inman","year":"1970","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2020.05.017_b0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/13625187.2013.792637","article-title":"Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism","volume":"18","author":"Bitzer","year":"2013","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"2","key":"10.1016\/j.contraception.2020.05.017_b0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/er.2012-1008","article-title":"Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects","volume":"34","author":"Stanczyk","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.contraception.2020.05.017_b0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","article-title":"Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study","volume":"312","author":"Spitzer","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2020.05.017_b0035","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2020.05.017_b0040","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1001\/archinte.1997.00440350022002","article-title":"A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy","volume":"157","author":"Douketis","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.contraception.2020.05.017_b0045","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.contraception.2009.12.014","article-title":"Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation \u201cpill scare\u201d","volume":"81","author":"Heinemann","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2020.05.017_b0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jfprhc-2011-100260","article-title":"Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets","volume":"8","author":"Dinger","year":"2012","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2020.05.017_b0055","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2016.06.010","article-title":"Impact of estrogen type on cardiovascular safety of combined oral contraceptives","volume":"94","author":"Dinger","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2020.05.017_b0060","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.contraception.2016.04.015","article-title":"Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA)","volume":"94","author":"Apter","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2020.05.017_b0065","unstructured":"United Healthcare Pharmacy, Clinical Pharmacy Programs, May 1, 2020. Available at https:\/\/www.uhcprovider.com\/content\/dam\/provider\/docs\/public\/prior-auth\/drugs-pharmacy\/commercial\/r-z\/COMM-PA-Med-Nec-Slynd.pdf. Accessed May 20, 2020."}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078242030175X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078242030175X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T21:11:00Z","timestamp":1762117860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001078242030175X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S001078242030175X"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2020.05.017","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral contraceptive generations \u2013 Time to stop using a marketing myth to define nomenclature","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2020.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}